Next-generation sequencing facilitates the diagnosis in a child with twinkle mutations causing cholestatic liver failure.

I n many disorders, overlapping clinical phenotypes and locus heterogeneity can significantly hamper making a clinical or molecular diagnosis. In both acute and cholestatic liver failure, making such a diagnosis has significant potential to alter the direction of therapy. In several large series, the majority of children with acute liver failure have no identifiable cause. It is the hope that new technologies may allow for rapid detection of all of the genetic causes of liver failure (1). Mitochondria are essential for the survival of eukaryotic cells. Their major function is to generate adenosine triphosphate, the energy for supporting cellular activities. Mitochondria contain their own DNA and machinery for transcription and translation. The replication, repair, transcription, and translation of mitochondrial DNA (mtDNA) depend on the protein components encoded by the nuclear genome (2,3). The C10orf2 gene encodes the mtDNA helicase TWINKLE, which is one of the proteins essential for mtDNA maintenance. Dominant mutations cause multiple mtDNA deletions and progressive external ophthalmoplegia (Online Mendelian Inheritance in Man no. 609286), and recessive mutations can lead to mtDNA depletion and infantile onset spinocerebellar ataxia (IOSCA) (Online Mendelian Inheritance in Man no. 271245). The clinical features of IOSCA include hypotonia, athetosis, ataxia, ophthalmoplegia, hearing deficit, sensory neuropathy, and epileptic encephalopathy. Previous cases have described patients with either homozygous (Y508C) or compound heterozygous (Y508C and A318T) TWINKLE mutations. A 20-year follow-up on 23 patients with IOSCA demonstrated that the common symptoms include refractory status epilepticus, migraine-like headaches, and severe psychiatric symptoms (4). We report on a child with compound heterozygous recessive TWINKLE mutations who presented at an early age with acute liver failure, subsequent neurologic decompensation, and Fanconi syndrome.

[1]  Song Zhang,et al.  Pattern of diagnostic evaluation for the causes of pediatric acute liver failure: an opportunity for quality improvement. , 2009, The Journal of pediatrics.

[2]  J. Ledingham,et al.  British Thoracic Society (BTS) recommendations for assessing risk and managing tuberculosis in patients due to start anti-TNF-{alpha} treatments. , 2005, Rheumatology.

[3]  W. Grody,et al.  ACMG recommendations for standards for interpretation and reporting of sequence variations: Revisions 2007 , 2008, Genetics in Medicine.

[4]  M. Weinblatt,et al.  Infections and anti-tumor necrosis factor alpha therapy. , 2003, Arthritis and rheumatism.

[5]  T. Matsuishi,et al.  SRD5B1 gene analysis needed for the accurate diagnosis of primary 3‐oxo‐Δ4‐steroid 5β‐reductase deficiency , 2009, Journal of gastroenterology and hepatology.

[6]  J. Sarles,et al.  Inappropriate liver transplantation in a child with Alpers–Huttenlocher syndrome misdiagnosed as valproate‐induced acute liver failure , 2000, Pediatric transplantation.

[7]  A. Paetau,et al.  Recessive Twinkle mutations in early onset encephalopathy with mtDNA depletion. , 2007, Brain : a journal of neurology.

[8]  V. Vullo,et al.  Evaluation of QuantiFERON-TB Gold In-Tube in human immunodeficiency virus infection and in patient candidates for anti-tumour necrosis factor-alpha treatment. , 2010, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

[9]  R. Carrozzo,et al.  Clinical and molecular features of mitochondrial DNA depletion due to mutations in deoxyguanosine kinase , 2008, Human mutation.

[10]  J. Keane,et al.  Tuberculosis associated with infliximab, a tumor necrosis factor alpha-neutralizing agent. , 2001, The New England journal of medicine.

[11]  J. Buckels,et al.  Generalised mitochondrial cytopathy is an absolute contraindication to orthotopic liver transplant in childhood. , 1998, Journal of pediatric gastroenterology and nutrition.

[12]  Robert Horsburgh,et al.  An official ATS/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases. , 2007, American journal of respiratory and critical care medicine.

[13]  W. Mow,et al.  High incidence of anergy in inflammatory bowel disease patients limits the usefulness of PPD screening before infliximab therapy. , 2004, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[14]  David P Bick,et al.  Making a definitive diagnosis: Successful clinical application of whole exome sequencing in a child with intractable inflammatory bowel disease , 2011, Genetics in Medicine.

[15]  Madhukar Pai,et al.  Systematic Review: T-Cellbased Assays for the Diagnosis of Latent Tuberculosis Infection: An Update , 2008, Annals of Internal Medicine.

[16]  S. Carr,et al.  A Mitochondrial Protein Compendium Elucidates Complex I Disease Biology , 2008, Cell.

[17]  D. Dimmock,et al.  Quantitative evaluation of the mitochondrial DNA depletion syndrome. , 2010, Clinical chemistry.

[18]  P. Cheeseman,et al.  Safety and efficacy of N‐acetylcysteine in children with non‐acetaminophen‐induced acute liver failure , 2008, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[19]  J. Cochran,et al.  Acute Liver Failure in Children , 2007, Pediatric emergency care.

[20]  Paula Buchanan,et al.  Liver transplantation cost in the model for end‐stage liver disease era: Looking beyond the transplant admission , 2009, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[21]  David C Wilson,et al.  Pediatric modification of the Montreal classification for inflammatory bowel disease: The Paris classification , 2011, Inflammatory bowel diseases.

[22]  J. Dunn,et al.  Abnormal neurological features predict poor survival and should preclude liver transplantation in patients with deoxyguanosine kinase deficiency , 2008, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[23]  U. Stenzel,et al.  Parallel tagged sequencing on the 454 platform , 2008, Nature Protocols.

[24]  William M. Lee,et al.  Intravenous N-acetylcysteine improves transplant-free survival in early stage non-acetaminophen acute liver failure. , 2009, Gastroenterology.

[25]  A. Paetau,et al.  Recessive twinkle mutations cause severe epileptic encephalopathy. , 2009, Brain : a journal of neurology.

[26]  J. Kaldor,et al.  Updated guidelines for using Interferon Gamma Release Assays to detect Mycobacterium tuberculosis infection - United States, 2010. , 2010, MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports.